bluebird bio : To Webcast Data Review, ZYNTEGLO Approval

bluebird bio (Nasdaq: BLUE) announced that the company will host a live webcast to review new data presented at the European Hematology Association (EHA) Annual Meeting, and to discuss the approval of ZYNTEGLO^® (autologous CD34+ cells encoding βA-T87Q-globin gene) on Friday, June 14 at 8:00 a.m. ET.

Investors may listen to the call by dialing (844) 825-4408 from locations in the United States or +1 (315) 625-3227 from outside the United States. Please refer to conference ID number 2189283.

To access the live webcast of bluebird bio’s presentation, please visit the “Events & Presentations” page within the Investors & Media section of the bluebird bio website at http://investor.bluebirdbio.com. Replays of the webcast will be available on the bluebird bio website for 90 days following the event.

https://www.marketscreener.com/BLUEBIRD-BIO-INC-13430435/news/bluebird-bio-Announces-Live-Webcast-of-EHA-Data-Review-and-ZYNTEGLO-autologous-CD34-cells-encod-28719151/